Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Akeso, Amgen, Aptorum, Argenx, Ascletis, Astrazeneca, Beigene, Canbridge, CASI, Daiichi Sankyo, Glenmark, Idorsia, Jacobio, Jeil, Juventas Cell Therapy, Neurophth, Novavax, Opko Health, Pfizer, Recbio Technology, Rockwell Medical, Senhwa, Shanghai Green Valley, Sorrento.